Gregory M. Lanza, MD, PhD

James R. Hornsby Family Professor of Biomedical Sciences

Gregory Lanza

Scientific Impact

  • 250+ peer reviewed publications
  • Co-inventor of a perfluorocarbon-based contrast agent, the first demonstrated in vitro
  • Co-Founder, board member and CSO, Kereos, Inc
  • Founder, Capella Imaging, LLC


  • Molecular imaging
  • Targeted therapeutics, Nanomedicine
  • Cardiology

Learn more